Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleNasdaq· March 26, 2026

Zacks Investment Ideas feature highlights: Arm Holdings, NVIDIA, Advanced Micro Devices, Apple, Qualcomm and Meta Platforms

View original at nasdaq.com
“ARM's 97.5% gross margin (total revenue – cost of goods sold) is exceptional.”
Verbatim excerpt from the source · Nasdaq · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Agentic AI is currently the fastest-growing area of the AI industry.

    60% confidence
  • The new data center chip business could generate approximately $15 billion in annual revenue in about five years.

    60% confidence
  • The new data center chip will ignite revenue growth.

    60% confidence
  • ARM Holdings is a Zacks Rank #3 (Hold) stock.

    60% confidence
  • ARM will grow revenue by approximately 20% over the next few years according to Zacks Consensus Estimates.

    60% confidence
  • Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.

    60% confidence
  • Wednesday's gap up in ARM stock is buyable based on the episodic pivot pattern.

    60% confidence
  • Wall Street will be forced to raise forward estimates in the coming months as they factor in the large potential of an in-house chip.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com